Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, I(f)

Circulation Research

Volumn 81, Issue 1, 1997, Pages 60-68

  Musialek, Piotr ^a,b   Lei, Ming ^a   Brown, Hilary F ^a   Paterson, David J ^a   Casadei, Barbara ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Heart rate; Hyperpolarization activated inward current; Nitric oxide; Nitrovasodilator; Sinoatrial node

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; LINSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; FEMALE; GUINEA PIG; HEART MUSCLE CONTRACTILITY; HEART RATE; HYPERPOLARIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; SINUS NODE; SINUS TACHYCARDIA;

EID: 0030988770     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.1.60     Document Type: Article

References (40)

1. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363-380.
2. Shah A, Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res. 1996;31:847-867.
3. Chen RY, Fan FC, Schuessler GB, Chien S. Baroreflex control of heart rate in humans during nitroprusside-induced hypotension. Am J Physiol. 1982;243:R18-R24.
4. Levine TB, Olivari MT, Cohn JN. Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure. Am J Cardiol. 1986;58:1035-1040.
5. De Marco T, Dae M, Yuen-Green MSF, Kumar S, Sudhir K, Keith F, Amidon T, Rifkin C, Klinski C, Lau D, Botvinick EH, Chatterjee K. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol. 1995;25:927-931.
6. Kennedy RH, Hicks KK, Brian JE, Seifen E. Nitric oxide has no chronotropic effect in right atria isolated from rat heart. Eur J Pharmacol. 1994;225:149-156.
7. Pabla R, Curtis MJ. Effects of No modulation on cardiac arrhythmias in the rat isolated heart. Circ Res. 1995;77:984-992.
8. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous No solutions. J Cardiovasc Pharmacol. 199l;17(suppl 3):S25-S33.
9. Feelisch M, Stamler JS. Donors of nitrogen oxides. In: Feelisch M, Stamler JS, eds. Methods in Nitric Oxide Research. New York, NY: John Wiley & Sons Inc; 1996:71-115.
10. f. J Physiol (Lond). 1990;429:401-409.
11. Leitch SP, Sears CE, Brown HF, Paterson DJ. Effects of high potassium and the bradycardic agents ZD7288 and cesium on heart rate of rabbits and guinea pigs. J Cardiovasc Pharmacol. 1995;25: 300-306.
12. f) in guinea-pig dissociated sinoatrial node cells. Br J Pharmacol. 1993;110:343-349.
13. Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol (Lond). 1988;395:233-253.
14. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456.
15. Mülsch A, Busse R, Liebau S, Förstermann U. LY83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J Pharmacol Exp Ther. 1988;247:283-288.
16. Cellek S, Kasakov L, Moncada S. Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclase. Br J Pharmacol. 1996;118:137-140.
17. Brunner F, Schmidt K, Nielsen EB, Mayer B. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exp Ther. 1996;277:48-53.
18. Han X, Shimoni Y, Giles WR. A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate. J Gen Physiol. 1995;106:45-65.
19. Campbell DL, Stamler JS, Strauss HC. Redox modulation of L-type calcium channels in ferret ventricular myocytes. J Gen Physiol. 1996;108:277-293.
20. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J. S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A. 1992;89:444-448.
21. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
22. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric-oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
23. K in rabbit sino-atrial node cells. Exp Physiol. 1996;81:725-741.
24. Kontos HA, Wei EP. Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583. Stroke. 1993;24:427-434.
25. Barbier AJ, Lefebvre RA. Effect of LY83583 on relaxation induced by non-adrenergic non-cholinergic nerve stimulation and exogenous nitric oxide in the rat gastric fundus. Eur J Pharmacol. 1992;219:331-334.
26. Irisawa H, Brown HF, Giles W. Cardiac pacemaking in the sinoatrial node. Physiol Rev. 1993;73:197-227.
27. Fung HL, Kowaluk EA, Chung SJ, Jhun BH, Seth P. Nitric oxide generation from nitrovasodilators in coronary artery smooth muscle cells is mediated by multiple enzymes. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA, eds. The Biology of Nitric Oxide: Physiological and Clinical Aspects. London, UK: Portland Press; 1992;1:139-141.
28. DiFrancesco D. The onset and autonomic regulation of pacemaker activity: relevance of the f current. Cardiovasc Res. 1995;29:449-456.
29. KACh. J Physiol (Lond). 1995;483:21P. Abstract.
30. Janigro D, West GA, Nguyen T-S, Winn HR. Regulation of Wood-brain barrier endothelial cells by nitric oxide. Circ Res. 1994; 75:528-538.
31. 2+ current in adult rabbit atrioventricular nodal cells. Circ Res. 1996;78:998-1008.
32. Reid IA, Chou L. Role of nitric oxide in the renin and heart rate responses to β-adrenergic stimulation. Hypertension. 1994;23(suppl I):I-49-I-53.
33. Sears CE, Paterson DJ. Role of nitric oxide in the rate and contraction responses to acetylcholine following adrenergic stimulation in the isolated frog heart. J Physiol (Lond). 1996;495:167P-168P. Abstract.
34. Conlon K, Collins T, Kidd C. Modulation of vagal actions on heart rate produced by inhibition of nitric oxide synthase in the anaesthetised ferret. Exp Physiol. 1996;81:547-550.
35. Malcolm AD. Clinical and hemodynamic effects of the new dilator drug molsidomine. Am Heart J. 1985;109:674-677.
36. Crystal GJ, Gurevicius J. Nitric oxide does not modulate myo- cardial contractility acutely in in situ canine hearts. Am J Physiol. 1996;270:H1568-H1567.
37. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion. Circulation. 1994;89:2070-2078.
38. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93:1087-1094.
39. Ungureanu-Longrois D, Balligand J-L, Kelly RA, Smith TW. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol. 1995;27:155-167.
40. f, in ventricular myocytes from human failing heart. Circulation. 1997;95:568-571.